Articles
View all articles-
Pfizer takes a shot at evasive superbug vaccine
Kathrin Jansen, a microbiologist with at least two breakthrough vaccines to her name is now taming the superbug MRSA, a drug-resistant bacterium for Pfizer. #Vaccine #PFIZER INC. #Superbug
-
India undermining intellectual property: Pfizer tells US lawmakers
Months after its patent for a cancer medication was revoked by India, American firm Pfizer has told US lawmakers that the country is undermining intellectual property by misuse of its compulsory licence provisions. #TheySaidIt #Pfizer #Intellectual property #cancer drugs
-
Pharma majors selling drugs at 10 times the cost: MCA
As per the findings that studied 21 formulations of big drug manufacturers, the mark up of maximum retail price over cost of production was the highest at 1,123% in case of GlaxoSmithkline #ToWhatEffect #Cipla #Dr. Reddy's Laboratories #GlaxoSmithKline #Pfizer
Wire
-
The Seattle Times
Pfizer plans offering to pare Zoetis stake
Drugmaker Pfizer Inc. plans to try to sell its controlling stake in its former animal health business, Zoetis Inc., through a voluntary stock exchange with Pfizer shareholders. Pfizer, the world's second-largest drugmaker, said Wednesday that its shareho #Pfizer Inc. #Facebook #Standard & Poor's
-
Yahoo! Health
Pfizer to spin off Zoetis stake to shareholders
(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7 percent discount. Pfizer, the largest drugmaker, sold Zoetis s #Pfizer Inc.
-
PharmaTimes
Pfizer drug fails in Phase III NHL trial
Pfizer's bid to expand its oncology portfolio has suffered a setback with the news that the drugs giant has halted a late-stage trial of inotuzumab ozogamicin in patients with an aggressive form of non-Hodgkin's lymphoma due to futility. The drugs giant #National Hockey League #Roche




